Langham Healthcare has completed its Series B financing, which was invested by a number of first-tier professional investment institutions, including the fund under the Chinese Academy of Sciences. The company has established a close clinical partnership with a number of top domestic teaching hospitalsThe outlook is very good.
Longcom Medical is a leading new generation of minimally invasive oncology interventional medical technology company in China. The company has established a close scientific research partnership with Tsinghua University, and has achieved fruitful results in the comprehensive layout of medical surgical robots as well as the technological development of minimally invasive and precise interventional surgical equipment and instruments for tumors.